Identification of HIV-1protease cleavage site in human C1-inhibitor

被引:7
|
作者
Gerencer, M
Burek, V
机构
[1] Univ Zagreb, Univ Hosp, Dept Cellular Immunol, Tissue Typing Ctr, HR-10002 Zagreb, Croatia
[2] Univ Zagreb, Univ Hosp Infect Dis Dr Fran Mihaljevic, Dept Clin Immunol, HR-10002 Zagreb, Croatia
关键词
HIV-1; protease; limited proteolysis; complement proteins; protease cleavage site; pathogenesis;
D O I
10.1016/j.virusres.2004.04.010
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have investigated the ability of HIV-1 protease to cleave human complement proteins of the classical complement pathway: C1q, C2 and C4 as well as the regulatory protein, C1-inhibitor. Purified complement proteins were incubated with recombinant HIV-1 protease in vitro and analyzed by SDS-PAGE and immunoblotting assay. The only cleavage site was found in N-terminal region of C1-inhibitor, and it was located between residues Leu-32 and Phe-33 as determined by amino acid sequence analysis of the 85 kDa proteolyfic fragment after 12 Edman degradation cycles. The HIV-1 protease cleavage sites were not found in C1q, C2 and C4 protein. HIV-1 protease-susceptible site in N-terminal region of C1-inhibitor is very close to the cleavage sites of some other proteases that are able to induce N-terminal proteolysis of the protein. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 50 条
  • [31] Cleavage of eIF4G by HIV-1 protease: effects on translation
    Perales, C
    Carrasco, L
    Ventoso, I
    FEBS LETTERS, 2003, 533 (1-3): : 89 - 94
  • [32] Predicting HIV-1 Protease Cleavage Sites With Positive-Unlabeled Learning
    Li, Zhenfeng
    Hu, Lun
    Tang, Zehai
    Zhao, Cheng
    FRONTIERS IN GENETICS, 2021, 12
  • [33] Incorporating the Coevolving Information of Substrates in Predicting HIV-1 Protease Cleavage Sites
    Hu, Lun
    Hu, Pengwei
    Luo, Xin
    Yuan, Xiaohui
    You, Zhu-Hong
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2020, 17 (06) : 2017 - 2028
  • [34] Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK
    Falls, Zackary
    Fine, Jonathan
    Chopra, Gaurav
    Samudrala, Ram
    FRONTIERS IN CHEMISTRY, 2022, 9
  • [35] Virtual Screening of Indonesian Herbal Database as HIV-1 Protease Inhibitor
    Yanuar, Arry
    Suhartanto, Heru
    Mun'im, Abdul
    Anugraha, Bram Hik
    Syahdi, Rezi Riadhi
    BIOINFORMATION, 2014, 10 (02) : 52 - 55
  • [36] Computational design of novel cyclic urea as HIV-1 protease inhibitor
    Vijjulatha, Manga
    Kanth, S. Sree
    CENTRAL EUROPEAN JOURNAL OF CHEMISTRY, 2007, 5 (04): : 1064 - 1072
  • [37] HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation
    Nie, Z
    Phenix, BN
    Lum, JJ
    Alam, A
    Lynch, DH
    Beckett, B
    Krammer, PH
    Sekaly, RP
    Badley, AD
    CELL DEATH AND DIFFERENTIATION, 2002, 9 (11) : 1172 - 1184
  • [38] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
    Barragan, Patricia
    Podzamczer, Daniel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375
  • [39] Effectively predicting HIV-1 protease cleavage sites by using an ensemble learning approach
    Hu, Lun
    Li, Zhenfeng
    Tang, Zehai
    Zhao, Cheng
    Zhou, Xi
    Hu, Pengwei
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [40] Evolutionary based optimal ensemble classifiers for HIV-1 protease cleavage sites prediction
    Singh, Deepak
    Singh, Pradeep
    Sisodia, Dilip Singh
    EXPERT SYSTEMS WITH APPLICATIONS, 2018, 109 : 86 - 99